The Impact of Paricalcitol on Parathyroid Gland Size of Secondary Hyperparathyroidism Patients with Long-Term Maintenance Hemodialysis: An Observational Study

被引：0
|
作者：
Tao, Chenghui [1 ]
Liao, Xiaohui [2 ]
机构：
[1] Peoples Hosp, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0552
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [21] EXPERIENCES WITH INTRAVENOUS ETELCALCETIDE IN LONG-TERM HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
    Pernat, Andreja Marn
    Gubensek, Jakob
    Cede, Ana Zupunski
    Knap, Bojan
    Persic, Vanja
    Trampuz, Barbara Vajdic
    Ponikvar, Jadranka Buturovic
    Ponikvar, Rafael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [22] Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study
    Koc, Hasan
    Hoser, Hasan
    Akdag, Yalcin
    Kendir, Cemaliye
    Ersoy, F. Fevzi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1261 - 1270
  • [23] Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover study
    Mittman, N.
    Khanna, R.
    Rani, S.
    Chattopadhyay, J.
    Avram, M. M.
    KIDNEY INTERNATIONAL, 2006, 70 : S64 - S67
  • [24] Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study
    Hasan Koc
    Hasan Hoser
    Yalcin Akdag
    Cemaliye Kendir
    F. Fevzi Ersoy
    International Urology and Nephrology, 2019, 51 : 1261 - 1270
  • [25] Decreases in Parathyroid Gland Volume after Cinacalcet Treatment in Hemodialysis Patients with Secondary Hyperparathyroidism
    Ichii, Mitsuru
    Ishimura, Eiji
    Okuno, Senji
    Chou, Hidenori
    Kato, Yoko
    Tsuboniwa, Naoki
    Nagasue, Kyoko
    Maekawa, Kiyoshi
    Yamakawa, Tomoyuki
    Inaba, Masaaki
    Nishizawa, Yoshiki
    NEPHRON CLINICAL PRACTICE, 2010, 115 (03): : C195 - C202
  • [26] Cinacalcet treatment significantly deceases parathyroid gland volume in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, Eiji
    Ichii, Mitsuru
    Okuno, Senji
    Inaba, Masaaki
    Nishizawa, Yoshiki
    ENDOCRINE JOURNAL, 2010, 57 : S491 - S491
  • [27] Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
    Keitaro Yokoyama
    Ryutaro Shimazaki
    Masafumi Fukagawa
    Tadao Akizawa
    Scientific Reports, 9
  • [28] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Shigematsu, Takashi
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Akiba, Takashi
    Fujii, Akifumi
    Odani, Motoi
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 426 - 436
  • [29] Long-term effects of small doses of calcitriol in hemodialysis patients with moderate secondary hyperparathyroidism
    Vlassopoulos, D
    Noussias, C
    Revenas, K
    Hadjilouka-Mantaka, A
    Arvanitis, D
    Tzortzis, G
    Hadjiconstantinou, V
    RENAL FAILURE, 1999, 21 (02) : 199 - 207
  • [30] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Takashi Shigematsu
    Masafumi Fukagawa
    Keitaro Yokoyama
    Takashi Akiba
    Akifumi Fujii
    Motoi Odani
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2018, 22 : 426 - 436
12345